The MedicX Fund Limited Acquisition of a new primary healthcare centre (5313L)
20 April 2018 - 2:27AM
UK Regulatory
TIDMMXF
RNS Number : 5313L
The MedicX Fund Limited
19 April 2018
For immediate release
19 April 2018
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Acquisition of a new primary healthcare centre
MedicX Fund Limited, (LSE: MXF), the specialist primary care
infrastructure investor in modern, purpose-built, primary
healthcare properties in the United Kingdom and Ireland, is pleased
to announce that it has contracted to acquire, by way of forward
funding, a new primary healthcare medical centre in Peterborough.
The property is due to be completed in April 2019.
The completed development will be let to the GPs of the
Nightingale Medical Practice. All leases will be for a term of 20
years from practical completion. The completed property will
consist of c.900 m(2) with 3 yearly reviews to market rent. The
total acquisition price including costs is expected to be GBP3.2
million.
MedicX Fund's total property portfolio now comprises 154
properties throughout the United Kingdom and Ireland of which 150
are operational and let, with four under construction. The
annualised rent roll for all properties is now GBP40.8 million.
Medicx Fund continues to be in active dialogue on a number of
investment opportunities in both the UK and Republic of Ireland
where it continues to take a disciplined approach to asset
selection.
- End -
For further information please contact:
Octopus Healthcare Adviser Ltd +44 (0) 345 0404 5555
Octopus Healthcare +44 (0) 20 3142 4820
Mike Adams, Executive Chairman
Buchanan +44 (0) 20 7466 5000
Charles Ryland/Henry Wilson
Information on MedicX Fund Limited
MedicX Fund Limited ("MXF", "MedicX Fund", the "Fund" or the
"Company", or together with its subsidiaries, the "Group") is the
specialist primary care infrastructure investor in modern,
purpose-built primary healthcare properties in the United Kingdom
and Ireland, listed on the London Stock Exchange, with a portfolio
comprising 154 properties.
The Investment Adviser to the Company is Octopus Healthcare
Adviser Ltd, which is part of the Octopus Healthcare group. Octopus
Healthcare invests in and develops properties as well as creating
partnerships to deliver innovative healthcare buildings to improve
the health, wealth and wellbeing of the UK. It currently manages
over GBP1.2 billion of healthcare investments across a number of
platforms, with a focus on five core areas: GP surgeries, care
homes, special education schools, retirement housing and private
hospitals. Octopus Healthcare is part of the Octopus group, a
fast-growing UK fund management business with leading positions in
several specialist sectors including healthcare property, energy,
property finance and smaller company investing. Octopus manages
GBP7.7 billion of funds for more than 50,000 retail and
institutional investors as well as supplying energy to more than
180,000 customers.
Octopus Healthcare Adviser Ltd is authorised and regulated by
the Financial Conduct Authority.
The Company's website address is www.medicxfund.com. Neither the
contents of the Company's website nor the contents of any website
accessible from hyperlinks on the Company's website (or any other
website), nor the contents of any website accessible from
hyperlinks within this announcement, are incorporated into, or
forms part of, this announcement.
The Company's Legal Entity Identifier is
2138008POF35FTNFCB25
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCQKLFFVZFLBBZ
(END) Dow Jones Newswires
April 19, 2018 12:27 ET (16:27 GMT)
Medicx (LSE:MXF)
Historical Stock Chart
From Apr 2024 to May 2024
Medicx (LSE:MXF)
Historical Stock Chart
From May 2023 to May 2024